Ashley Mansell Lorne Infection and Immunity 2023

Abstracts this author is presenting:

• ADS032, the first dual NLRP1 and NLRP3 inflammasome inhibitor for the treatment of infectious and inflammatory diseases — Session 2: Innate Immunity